Breaking News
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Biden to Turn Up Pressure on Democrats Balking at Spending Bill

PoliticsSep 16, 2021 14:02
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters

(Bloomberg) -- President Joe Biden is set to ratchet up pressure on congressional Democrats on Thursday, as discord within the party threatened to derail key pieces of his economic agenda, including lowering prescription drug prices and some of his proposed tax hikes on the wealthiest Americans.

In a speech Thursday at the White House, Biden plans to urge Democrats to unite, focusing on the struggles of middle class families -- such as the prices of prescription drugs, hearing aids and high-speed internet, as well as the more general costs of raising a child -- said a White House official. 

The recent back-and-forth on Capitol Hill has shown the limits of Biden’s power to guide the $3.5 trillion plan through a narrowly divided Congress. Moderate Democrats have balked at recent efforts to negotiate on drug prices and to impose a new tax on the assets of the wealthiest people, measures that progressives applaud.  

The White House can only afford to lose the support of three House Democrats for the package to pass; it needs all Democratic votes in the Senate. 

On Wednesday, Biden hosted two moderate Democratic senators -- Joe Manchin of West Virginia and Kyrsten Sinema of Arizona -- for separate meetings at the White House. Manchin has pushed for a spending package less than half of Biden’s proposal, a move that risks delaying the president’s package by weeks or months in Congress with tax, health care and other issues still unresolved. 

White House aides have spent the last several days negotiating and speaking with lawmakers and top staffers to weigh various options to raise enough money to fully fund Biden’s plan and ensure as many big policies as possible survive the legislative process.

Progressives have been disappointed as House Democratic lawmakers shied away from ideas like taxing the increase of wealthy people’s assets at death -- a key pillar of Biden’s attempts to reduce income inequality. Just this week, after intense lobbying from the health-care industry, a handful of moderate Democrats also backed away from efforts to negotiate lower prescription drug prices.

Democratic Representatives Kurt Schrader of Oregon, Scott Peters of California and Kathleen Rice of New York joined Republicans in voting against a bill to allow the government to demand lower prices from drugmakers and cap price increases on some medicines. The measure failed to advance, in a tied committee vote.

©2021 Bloomberg L.P.

Biden to Turn Up Pressure on Democrats Balking at Spending Bill
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email